Up and down quarter for Olympus

The company’s first quarter of its 2024 fiscal year was a mixture of results and showed that some things are changing on the international business scene.

Related Keywords

Pennsylvania ,United States ,China ,Japan ,Tokyo ,Shanghai ,New York ,Center Valley ,Ukraine ,Lake Success ,Japanese ,America ,Cholangio Pancreatography ,Asia Pacific ,Chikasi Takeda ,Olympus Terumo Biomaterials Corporation ,Therapeutic Solutions Division ,Olympus Group ,Olympus Corporation Of America ,Therapeutic Solutions Business ,Olympus Corporation Of The Americas ,Endoscopic Solutions Business ,Olympus Corporation ,Endoscopic Solutions Division ,North America ,Endoscopic Retrograde Cholangio Pancreatography ,Endoscopic Submucosal Dissection ,Endoscopic Mucosal Resection ,Benign Prostatic Hyperplasia ,Pulsed Laser System ,Olympus Terumo Biomaterials ,2024 Fiscal Year ,